BRPI1013089A2 - alimento medicinal, e, métodos para preparar um alimento medicinal, e para tratar um distúrbio metabólico - Google Patents

alimento medicinal, e, métodos para preparar um alimento medicinal, e para tratar um distúrbio metabólico

Info

Publication number
BRPI1013089A2
BRPI1013089A2 BRPI1013089A BRPI1013089A BRPI1013089A2 BR PI1013089 A2 BRPI1013089 A2 BR PI1013089A2 BR PI1013089 A BRPI1013089 A BR PI1013089A BR PI1013089 A BRPI1013089 A BR PI1013089A BR PI1013089 A2 BRPI1013089 A2 BR PI1013089A2
Authority
BR
Brazil
Prior art keywords
medicinal food
treating
preparing
methods
metabolic disorder
Prior art date
Application number
BRPI1013089A
Other languages
English (en)
Inventor
Denise M Ney
Mark R Etzel
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42677045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1013089(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of BRPI1013089A2 publication Critical patent/BRPI1013089A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI1013089A 2009-06-12 2010-06-11 alimento medicinal, e, métodos para preparar um alimento medicinal, e para tratar um distúrbio metabólico BRPI1013089A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18669009P 2009-06-12 2009-06-12
PCT/US2010/038340 WO2010144821A1 (en) 2009-06-12 2010-06-11 Glycomacropeptide medical foods for nutritional management of phenylketonuria and other metabolic disorders

Publications (1)

Publication Number Publication Date
BRPI1013089A2 true BRPI1013089A2 (pt) 2016-04-05

Family

ID=42677045

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1013089A BRPI1013089A2 (pt) 2009-06-12 2010-06-11 alimento medicinal, e, métodos para preparar um alimento medicinal, e para tratar um distúrbio metabólico

Country Status (14)

Country Link
US (3) US8604168B2 (pt)
EP (1) EP2440232B1 (pt)
JP (1) JP2012530067A (pt)
CN (2) CN102481338A (pt)
AU (1) AU2010259975B2 (pt)
BR (1) BRPI1013089A2 (pt)
CA (1) CA2764571C (pt)
CL (1) CL2011003120A1 (pt)
DK (1) DK2440232T3 (pt)
ES (1) ES2669094T3 (pt)
MX (1) MX2011013126A (pt)
NZ (1) NZ596902A (pt)
PT (1) PT2440232T (pt)
WO (1) WO2010144821A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012004585A1 (en) * 2010-07-09 2012-01-12 Abdulla Badawy Ingestible formulation comprising glycomacropeptide and at least one of tryptophan, tyrosine and phenylalanine and uses thereof
US9180168B2 (en) * 2012-01-31 2015-11-10 Wisconsin Alumni Research Foundation Use of glycomacropeptide to improve women's health
EP2831098A4 (en) 2012-03-26 2016-12-07 Axcella Health Inc LOADED NUTRIENT PROTEINS AND METHODS
CA2868469A1 (en) 2012-03-26 2013-10-03 Pronutria, Inc. Nutritive fragments, proteins and methods
SG11201405841RA (en) * 2012-03-26 2014-10-30 Pronutria Inc Nutritive fragments, proteins and methods
HK1206764A1 (en) 2012-03-26 2016-01-15 Axcella Health Inc. Nutritive proteins and methods
AU2013346732B2 (en) 2012-11-15 2017-02-02 Arla Foods Amba Method of producing a composition containing caseinomacropeptide
FR3002831B1 (fr) * 2013-03-11 2015-07-17 Lactalis Nutrition Sante Produit alimentaire pret a consommer pour patients atteints d'une maladie du metabolisme d'un ou de plusieurs acides amines
WO2014171813A1 (en) * 2013-04-17 2014-10-23 N.V. Nutricia Nutritional composition for improving brain function in phenylketonuria
CN103462003A (zh) * 2013-08-13 2013-12-25 甘肃华羚生物技术研究中心 苯丙酮尿症病患者专用特膳食品
SG11201602012RA (en) 2013-09-25 2016-04-28 Pronutria Inc Compositions and formulations for maintaining and increasing muscle mass, strength, and performance and methods of production and use thereof
WO2015059248A1 (en) 2013-10-23 2015-04-30 Arla Foods Amba High protein denatured whey protein composition, related products, method of production and uses thereof
PL3071047T5 (pl) 2013-10-23 2023-05-15 Arla Foods Amba Wysokobiałkowe kompozycje zdenaturowanego białka serwatkowego zawierające kazeinomakropeptyd, zawierające je produkty i ich zastosowania
JP6830813B2 (ja) 2013-10-23 2021-02-17 アーラ フーズ エエムビエＡｒｌａ Ｆｏｏｄｓ ａｍｂａ 高タンパク果実風味飲料、高タンパク果実および野菜調製物、ならびに関連する方法および食品
CA2881076C (en) 2014-02-06 2022-06-07 Cambrooke Foods, Inc. Liquid nutritional formula for phenylketonuria patients
WO2016003263A1 (en) * 2014-07-01 2016-01-07 N.V. Nutricia Amino acid based diet with improved taste
US10124036B2 (en) * 2015-06-12 2018-11-13 Cambrooke Therapeutics, Inc. Liquid nutritional formula for tyrosinemia patients
WO2018081175A1 (en) * 2016-10-24 2018-05-03 Habit, Llc System and method for implementing meal selection based on vitals, genotype, and phenotype
IT201800006268A1 (it) * 2018-06-13 2019-12-13 Formulazione nutrizionale per la gestione della dieta per la fenilchetonuria e metodo di realizzazione
CN113264988B (zh) * 2019-09-27 2022-12-06 湖北康肽药业有限公司 一组特殊膳食蛋白质
IT202000008203A1 (it) * 2020-04-17 2021-10-17 D M F Dietetic Metabolic Food S R L Composizione nutrizionale per il trattamento delle malattie metaboliche
AU2024365830A1 (en) 2023-10-27 2026-04-09 Société des Produits Nestlé S.A. Paediatric formulations for phenylketonuria and tyrosinaemia and specific free amino acid mixture

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8823804D0 (en) * 1988-10-11 1988-11-16 Holgates Nutritional Foods Ltd Proteinaceous composition
US5215750A (en) * 1991-09-04 1993-06-01 Keane Ii Michael A L-glutamine and vitamin-containing compositions effective for inducing weight loss and for weight control
EP0923315B1 (en) 1996-08-30 2003-12-10 Societe Des Produits Nestle S.A. Nutritional formula for phenylketonuria patients
US5968586A (en) 1997-10-09 1999-10-19 Wisconsin Alumni Research Foundation Production of κ-casein macropeptide for nutraceutical uses
US6168823B1 (en) * 1997-10-09 2001-01-02 Wisconsin Alumni Research Foundation Production of substantially pure kappa casein macropeptide
EP1325743A4 (en) * 2000-10-13 2004-12-15 Chugai Pharmaceutical Co Ltd COMPOSITIONS TO IMPROVE FAT METABOLISM
US20040077530A1 (en) * 2002-10-18 2004-04-22 Robert Portman Composition for reducing caloric intake
WO2005035001A1 (en) * 2003-09-29 2005-04-21 Enos Pharmaceuticals, Inc. Sustained release l-arginine formulations and methods of manufacture and use
US7744930B2 (en) * 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
US7951410B2 (en) 2003-04-14 2011-05-31 Mead Johnson Nutrition Company Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
PT3138566T (pt) * 2003-11-17 2022-02-02 Biomarin Pharm Inc Tratamento de fenilcetonúria com bh4
JP2008527020A (ja) * 2005-01-18 2008-07-24 ディーエスエム アイピー アセッツ ビー．ブイ． 新規な栄養補助組成物

Also Published As

Publication number Publication date
AU2010259975B2 (en) 2014-10-23
CN106983854A (zh) 2017-07-28
CA2764571A1 (en) 2010-12-16
AU2010259975A1 (en) 2011-12-22
CL2011003120A1 (es) 2012-05-25
US8604168B2 (en) 2013-12-10
JP2012530067A (ja) 2012-11-29
US10258074B2 (en) 2019-04-16
US20100317597A1 (en) 2010-12-16
DK2440232T3 (en) 2018-04-30
WO2010144821A1 (en) 2010-12-16
CA2764571C (en) 2018-12-18
NZ596902A (en) 2013-09-27
MX2011013126A (es) 2012-02-13
EP2440232A1 (en) 2012-04-18
CN102481338A (zh) 2012-05-30
PT2440232T (pt) 2018-03-23
EP2440232B1 (en) 2018-02-28
US20140248414A1 (en) 2014-09-04
ES2669094T3 (es) 2018-05-24
US20130196024A1 (en) 2013-08-01

Similar Documents

Publication Publication Date Title
BR112013033270A2 (pt) cápsulas, aparelho e métodos para preparar uma bebida
BR112013015221A2 (pt) cápsula, sistema e método para o preparo de uma bebida
BR112012033790A2 (pt) cápsula,dispositivo e método para preparar uma bebida por extração
IL231386A0 (en) Pyrazoloquinolinone derivatives, their preparation and medical use
PL2672966T3 (pl) Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania
IL228209B (en) A composition comprising a chromium-insulin complex and uses therefor for treating a glucose metabolism-related disease or disorder
BR112014008603A2 (pt) tablete, e, método para produzir um tablete
BR112013022559A2 (pt) cartão, e, método para fabricar um cartão
SG11201401998VA (en) Vaccines directed against human enteroviruses
ZA201300957B (en) 5-chloro-4-hydroxy-1-methyl-2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide, salts and use thereof
BRPI1013878A2 (pt) método para tratar distúrbios metabólicos, e, composto
BRPI1008643B8 (pt) recheio alimentício cremoso, e, método para formar um recheio alimentício cremoso
BR112013031712A2 (pt) composto, composição farmacêutica, métodos para preparar um composto e para o tratamento de um distúrbio ou uma doença.
BR112014013188A2 (pt) documento de segurança, e método para fabricar um documento de segurança
IL231444A (en) Aniline derivatives, their preparation and their medical application
IL233238A0 (en) Sulphonylaminopyrrolidinone derivatives, their preparation and therapeutic use
SG11201400204VA (en) Fish anesthetic and method
BR112012014011A2 (pt) mistura compatibilizada, artigo e método para preparar uma mistura compatibilizada
BR112014009360A2 (pt) folha, e, método para formar folha sequestrante de oxigênio
EP2730585A4 (en) PROTEIN-PEPTIDE COMPLEX HAVING SPECIFIC ACTION ON DERMAL TISSUES, PRODUCTION METHOD AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
BRPI0914170A2 (pt) recipiente para produtos médicos e método para produção do referido recipiente
BR112013013415A2 (pt) composição farmacêutica, e, método para a preparação de uma composição
BR112013013611A2 (pt) documento de segurança, e método para fabricar um documento de segurança
BR112013030097A2 (pt) recheio doce (variantes ) e métodos para fazer o mesmo
BR112014013781A2 (pt) laminado, e método para fabricar um laminado

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]